This is unsurprising when considering that brain structures located here have clinical correlates to well‐defined AD symptoms (e.g. memory impairments – hippocampus; altered emotional responses – amygdala), and that APOE4 carriers are at increased risk of developing these symptoms in the form of AD. The gene discussed is APOE; the disease is memory impairment.